Joyce Rodrigues de Souza

Calcium phosphate cements (CPCs) and biomaterials, such as mesoporous bioactive glass (MBG), are critical for bone tissue engineering. This study aimed to 3D-print CPC scaffolds modified with MBG to enhance their osteogenic potential and regenerative ability. MBG powder was synthesized and characterized using transmission electron microscopy (TEM), X-ray diffraction (XRD), and nitrogen adsorption–desorption techniques. A commercial CPC ink (hydroxyapatite/α-tricalcium phosphate) was mixed with 5% MBG (w/w; CPC/MBG), and, after rheological assessment, the mixture was used to obtain scaffolds via 3D printing. These scaffolds were then tested for chemical, morphological, and mechanical properties, as well as ion release analysis. Unmodified CPC 3D-printed scaffolds served as controls. Biological experiments, including cell viability, DNA content, cell adhesion/spreading, and osteogenic gene expression, were performed by seeding alveolar bone-derived mesenchymal stem cells onto the scaffolds. Statistics were performed using Student’s t-test and ANOVA with post hoc tests (α = 5%). MBG characterization showed a typical mesoporous structure with aligned microchannels and an amorphous structure. Both formulations released calcium and phosphate ions; however, CPC/MBG also released silicon. Cell viability, adhesion/spreading, and DNA content were significantly greater in CPC/MBG scaffolds compared to CPC (p < 0.05) after 3 and 7 days of culture. Furthermore, CPC/MBG supported increased expression of key osteogenic genes, including collagen (COL1A1), osteocalcin (OCN), and Runt-related transcription factor 2 (RUNX2), after 14 days (p < 0.05). The combination of CPC ink with MBG particles effectively enhances the biocompatibility and osteogenic potential of the scaffold, making it an innovative bioceramic ink formulation for 3D printing personalized scaffolds for bone regeneration.

Using bioactive glasses (BGs) for bone reconstruction is a promising and expanding field of investigation in regenerative medicine. Therefore, the aim of this study was to assess the key features of the 100 most cited papers on BG in bone tissue engineering through bibliometric measures. A search was conducted in the Web of Science citation indexing database until October 2023. Three researchers performed study selection and data extraction. Data extraction included publication title and year, authors, number of citations and mean number of citations, institution, country and continent, study design, journal, keywords, and bioactive glasses. Citation counts were also collected in Google Scholar and Scopus databases. Graphical bibliometric networks were created using VOSviewer software. The number of citations of the 100 most cited articles ranged from 118 to 1836, with ten papers cited more than 400 times. Articles were mostly published between 2011 and 2012. Most papers, comprising 72 in vitro studies, originated from the United States (n = 22) and were published in Biomaterials (27%). Aldo Boccaccini was the most cited author (n = 17; 6332 citations). The most prolific institution was Imperial College London (n = 19; 7073 citations), followed by Missouri University (USA; n = 7; 2494 citations). "Bioactive glass" was the most frequent keyword, with 46 occurrences. Laboratory-based studies, primarily conducted in the United States, evaluating the physicochemical, osteogenic properties, and antibacterial activity of silica-based bioactive glasses such as 45S5 have been the most cited thus far.

The integration of bioglass with polymers in tissue engineering scaffolds holds promise for enhancing bone regeneration. This study explores the fabrication and characterization of composite scaffolds comprising polylactic acid (PLA)/polyethylene glycol (PEG) fibers incorporated with silicate‐chlorinated bioglasses (45S5 and 58S). Electrospinning was utilized to produce the scaffolds, followed by physical–chemical and in vitro evaluations. Scanning electron microscopy (SEM) revealed uniform fiber formation, with bioglass incorporation observed in the composite groups. Bioglass incorporation led to a significant reduction in fiber diameter. Thermogravimetric analysis (TGA) estimated bioglass content, with 58S exhibiting the highest incorporation. Contact angle measurements indicated enhanced hydrophilicity in bioglass‐containing groups. In vitro, bioactivity assessment in simulated body fluid (SBF) demonstrated apatite formation potential and the pH variance indicates a slightly alkaline to neutral condition. Cell culture studies revealed robust cellular adhesion and metabolic activity across all groups, with no cytotoxic effects observed. Overall, these findings suggest the potential of PLA/PEG bioglass composite scaffolds for bone tissue engineering applications.

Poly(3‐hydroxybutyrate‐co‐3‐hydroxyvalerate) (PHBV) nanofibers embedded with borate glasses of 45B5 composition doped with Co²⁺, Cu²⁺, and Zn²⁺(46.1 B₂O₃26.9‐X CaO24.4 Na₂O2.6 P₂O₅, X CoO/CuO/ZnO mol % (X = 0–5)) were produced by electrospinning for wound healing applications. Prior to their addition, the glasses exhibited two broad halos typical of a vitreous borate network, which were mainly composed of ring‐type metaborate structural units. The particle distribution in the PHBV nanofibers embedded with 45B5 borate bioactive glasses is present in isolated and agglomerated states, being partially coated by a polymeric layer—except for the cobalt‐doped glass, which resulted in a successful encapsulation with 100% embedding efficiency. The incorporation of the glasses reduced the PHBV crystallinity degree and its decomposition temperature, as well as its mechanical properties, including Young's modulus, tensile strength, and elongation at break. The neat PHBV fibers and those containing the cobalt‐doped glasses demonstrated great cytocompatibility with human keratinocytes (HaCat), as suggested by the high cell viability after 7 days of exposure. Further studies are needed to fully understand the wound healing potential of these fibers, but our results significantly contribute to the area.

The field of tissue engineering has witnessed significant advancements in recent years, driven by the pursuit of innovative solutions to address the challenges of bone regeneration. In this study, we developed an electrospun composite scaffold for bone tissue engineering. The composite scaffold is made of a blend of poly(L‐lactide‐co‐ε‐caprolactone) (PLCL) and polyethylene glycol (PEG), with the incorporation of calcined and lyophilized silicate‐chlorinated bioactive glass (BG) particles. Our investigation involved a comprehensive characterization of the scaffold's physical, chemical, and mechanical properties, alongside an evaluation of its biological efficacy employing alveolar bone‐derived mesenchymal stem cells. The incorporation of PEG and BG resulted in elevated swelling ratios, consequently enhancing hydrophilicity. Thermal gravimetric analysis confirmed the efficient incorporation of BG, with the scaffolds demonstrating thermal stability up to 250°C. Mechanical testing revealed enhanced tensile strength and Young's modulus in the presence of BG; however, the elongation at break decreased. Cell viability assays demonstrated improved cytocompatibility, especially in the PLCL/PEG+BG group. Alizarin red staining indicated enhanced osteoinductive potential, and fluorescence analysis confirmed increased cell adhesion in the PLCL/PEG+BG group. Our findings suggest that the PLCL/PEG/BG composite scaffold holds promise as an advanced biomaterial for bone tissue engineering.

The development of bioactive membranes with bone repair properties is great interest in the field of tissue engineering. In this study, we aimed to fabricate and characterize a composite membrane composed of sol–gel synthesized bioceramics and electrospun polycaprolactone (PCL) fibers for bone tissue regeneration applications. The bioceramics were prepared using the sol–gel method with nitrate (N) and chloride (CL) as precursors. PCL and bioceramic solutions were electrospun to obtain ultrafine fiber mats. Raman spectroscopy, x‐ray diffraction (XRD), Fourier Transform Infrared spectroscopy (FTIR), thermogravimetric analysis (TGA), and scanning electron microscopy (SEM) were used to characterize the materials. The results showed that both chlorinated and non‐chlorinated bioceramics contained NBOs (non‐bridge bonds) and crystallized the α‐wollastonite phase, with the chlorinated version doing so at lower temperatures. In vitro tests were performed to evaluate cytotoxicity, cell adhesion, and mineralized matrix formation on the membranes. The composite membranes showed improved cell viability and promoted mineralization nodules formation. This study presents a promising approach for the development of bioactive membranes for bone tissue engineering, with potential applications in bone regeneration therapies.

The development of nanoscale biomaterials associated with polymers has been growing over the years, due to their important structural characteristics for applications in biological systems. The present study aimed to produce and test polymeric scaffolds composed of polylactic acid (PLA) fibers associated with a 58S bioglass doped with therapeutic ions for use in tissue engineering. Three 58S Bioglass was obtained by the sol–gel route, pure and doped with 5% strontium and cobalt ions. Solutions of 7% PLA was used as control and added the three different bioglass, 4% of 58S bioglass (PLA‐BG), 4% bioglass‐doped strontium (PLA‐BGSr) and 4% bioglass‐doped cobalt (PLA‐BGCo). Scaffolds were produced through electrospinning process, and was characterized chemical and morphologically. The in vitro tests were performed using mesenchymal cells cultures from femurs of nine rats, grown in osteogenic supplemented total culture medium. After osteoblastic differentiation induction cell viability, alkaline phosphatase activity, total protein content quantification, and visualization of mineralization nodule tests were performed. Analysis of normal distribution used the Shapiro–Wilk test (nanofibers diameter and biological assay). Data were compared using the Kruskal–Wallis nonparametric test (p = 0.05). The bioglasses produced proved to be free of nitrate, chlorinated and nano‐sized, with effective incorporation of therapeutic ions in their structure. All materials showed cell viability (>70%), total protein production, and alkaline phosphatase activity. It was possible to develop polylactic acid scaffolds associated with 58S bioglass doped with therapeutic ions without cytotoxicity. Scaffolds characteristics appear to sustain its application in bone tissue engineering.

Objetivos: A presente revisão de literatura teve por objetivo verificar na literatura atual a aplicabilidade da customização de pinos de fibra de vidro pré-fabricados com resina composta para situações clínicas. Materiais e métodos: Foi realizada uma pesquisa na base de dados PubMed utilizando as palavras-chave: Non-vital tooth, Post and Core Technique e Composite Resins. A busca foi limitada ao período de 2015 a 2021, de estudos publicados na íntegra, em inglês e acesso gratuito. Resultados: foram obtidos 1.981 artigos no PubMed, sendo 429 no período de 2015 a 2021. Após a leitura dos títulos e resumos foram excluídos 422 artigos. Ao final foram selecionados 5 artigos, sendo posteriormente acrescentado 4 artigos por referência cruzada, totalizando 9 artigos. Conclusão: Os pinos de fibra de vidro pré-fabricados customizados com resina composta são uma opção viável para reabilitação de dentes tratados endodonticamente com canal amplo e/ou frágil.